Mutations in the CDKN2A gene, which are linked to the familial atypical multiple mole-melanoma (FAMMM) syndrome, are associated with a 13- to 22-fold increased risk of pancreatic cancer [40]. Here, CDKN2A is linked to familial pancreatic carcinoma.